Q1. What is the success rate of this therapy?

A1. Since the energy transfer occurring in the cancerous tissue during the L.I.E.S.H. Therapy is one sufficient to generate death of the cells by suffocation, all pre-conditioned neoplastic tissue will die when exposed to the particular LASER’s light, independently from the nature and structure of the tissue where the cancer is occurring. In other words, as long as the entire neoplastic mass is exposed to the LASER light for the correct amount of time, the success is complete; and the results, as well as the healing stages, are always the same.

Q2. What type of cancer can be treated with this therapy?

A2. Again, the L.I.E.S.H. Therapy is simply a much improved form of Photo-Dynamic Therapy and in principle it may be used for any type of cancer; at this time however we are only handling breast cancer, all types of skin cancer and any other type of malignant growth occurring within 4 inches of the surface of the skin.

Q3. If the results are always the same, why can’t this therapy be used for cancer of the internal organs?

A3. We repeat, due to the type of energy transfer occurring in the preconditioned tissue when exposed to this particular light, any type of cancerous tissue will die, but for internal organs occurrences, it would be necessary to first access the location in question; this would render the procedure at least partially invasive and therefore not suited for an outpatient environment, which is what we are offering at this time.

Q4. How much pain can a patient expect to face?

A4. Actually, not much discomfort is involved; the pain is limited to the initial injection of a local anesthetic.

Q5. How long does the full treatment take?

A5. That depends on the size of the neoplastic growth, but on average the full treatment requires about 5 to 7 days, with daily visits to our Treatment Center for no more than two hours at a time.

Q6. What kind of side effects can a patient expect?

A6. The first couple of days the patient might experience a mild soreness of the treated area, after that a general feeling of well being takes over.

Q7. How long does a patient need to wait before he or she can determine if the treatment was effective?

A7. Besides the feeling of improved general health, before the patients can return home, we perform the necessary testing to confirm the death of the tumor(s). We show all patients the results which confirm that the tumor mass is dead or dying.

Q8. What type and extent of follow-up does this treatment entail?

A8. We encourage our patients to keep in touch with us after they return home; we will help with any question or doubt they might have. We want our patients to understand everything that is happening to them, and to feel good about their cancer experience; because after all, their cancer is dead!
Still we ask our patients to go for follow-up testing, every three months for a year, following our treatment; we ask them to send us the results. After the first three months, if  patients so wish, they can undergo an CT scan.

Q9. What about metastasis and reoccurrences?

A9. Since, as with any other malady, nobody can totally eliminate the chance of reoccurrences, we also cannot absolutely guarantee that the cancer will never return; with our method, we simply greatly reduce the chances of reoccurrence. However, should the cancer come back at any time, it can be retreated in full, as many times as needed, due to the total absence of negative side-effects intrinsic of our treatment.

Q10. What restrictions are indicated for a patient during and following the week of treatment?

A10. None; there are no restrictions in activities or diet  prescribed to the patients. We suggest to simply control the excessive euphoria that sooner or later takes over the individual receiving our therapy; however we do not discourage celebration parties!

Q11. Exactly how expensive is it to receive this treatment?

A11. Although the price varies, depending on the size and number of the malignant growths, it is still an amount comparable to deductible and co-pay covered by a patient undergoing surgical removal of a tumor.